AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback